Application Nr Approved Date Route Status External Links
NDA021284 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ritalin La ® Is Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd), In Pediatric Patients 6 To 12 Years Of Age [See Clinical Studies (14)]. Ritalin La Is A Central Nervous System (Cns) Stimulant Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) In Pediatric Patients 6 To 12 Years Of Age ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Methylphenidate Hydrochloride METHYLPHENIDATE HYDROCHLORIDE ZINC2522648

Comments